Harrow Health Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.18 billion, with shareholders equity totaling $28.83 million.
The company employs approximately 125 people and operates in the Health sector, within the Major Drugs industry.
Over the past 12 months, Harrow Health Inc. reported $303.25 million in revenue, generating net income of $-28.49 million.
Key financial metrics include a P/E ratio of -41.29, a price-to-book (P/B) ratio of 40.80, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker HROW.